Pembrolizumab With and Without Radiotherapy for Non-Small Cell Lung Cancer

Clinical trial NCT03217071 · COMPLETED

Trial details

NCT number: NCT03217071
Sponsor: Sue Yom
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer

Start date: 2017-10-04
Primary completion: 2022-03-31
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.